INDUSTRIES | PHARMACEUTICALS
Pharma operations and procurement advisory.
Operating experience from MSD/Merck and Organon, including the operational side of a major pharmaceutical spin-off. SreedharK Advisors helps pharma leaders rebuild procurement, supply governance and planning when the business is changing shape.
PHARMACEUTICALS
Separation without disruption
Contracts, supply agreements and planning governance rebuilt while the existing business keeps running.
Where pharma operations get stuck
Portfolio separations
Carve-outs that need procurement and supply rebuilt from a clean sheet.
Multi-market complexity
Supply agreements and planning governance spread across several Asian markets.
Unclear decision rights
Teams unsure who owns which operating decisions after a change in structure.
Time pressure
Change that has to happen while the existing business continues to operate.
How SreedharK Advisors helps
01
Supplier renegotiation and contract rebuild
02
Interim supply chain governance
03
A planning cadence fit for an independent entity
04
Clear decision rights for the new organisation
How it works
Every engagement starts with a diagnostic, not a proposal. The BRIDGE Model structures the work across six operating dimensions, and the Stakeholder Spectrum Diagnostic maps the people and decision points that decide whether change sticks.
PHARMA SECTOR | OPERATIONAL SEPARATION AND STABILISATION
Case study: pharma operational separation
A global pharmaceutical company separated its women’s health and specialty portfolio into a standalone business across multiple Asian markets. It entered its standalone phase with contracts in place, a functioning procurement structure and a team that understood its own decision rights.
Related: